Market Overview:
The global pain management product market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of chronic diseases, increasing geriatric population, and growing demand for minimally invasive procedures. The opioids segment is expected to dominate the global pain management product market in terms of revenue during the forecast period. This segment is projected to grow at a CAGR of 5.9% from 2018 to 2030 due to the high prevalence of chronic pain and increasing use of opioids for managing various types of pain conditions. The non-narcotic analgesics segment is projected grow at a higher CAGR (6%) during the forecast period owing its benefits over opioid analgesics such as lower risk for addiction and dependence, fewer side effects, and lower cost.
Product Definition:
A pain management product is a medication or other treatment that helps reduce or manage pain. Pain can be caused by many things, including injuries, diseases, and nerve damage. Pain management products can help people feel better and improve their quality of life.
Opioids:
Opioids are drugs that bind to the MOR (m opioid receptor) and/or DOR (delta opioid receptor) with high affinity. They are naturally occurring substances found in the latex of the Opium Poppy plant, as well as other plants such as morphine, codeine and papaver Somniferum.
The most commonly used opioids include Hydrocodone bitartrate tablets by Purdue Pharma L.P.
Non-narcotic Analgesics:
Non-narcotic analgesics are drugs that produce analgesia by decreasing the perception of pain. Opioids, NSAIDs, and local anesthetics are some examples of non-narcotic analgesics. These products have been used in pain management for a very long time because they were the only options available back then.
Application Insights:
The clinics segment dominated the global pain management product market in 2017. The application of pain management products is increasing at clinics due to the availability of these products without prescription. Moreover, patients with chronic pains are advised to practice regular exercise and engage in a healthy lifestyle which helps reduce their chronic aches and pains. This has led to an increase in demand for effective pain management treatments that do not have any restrictions on usage at clinics as well as homecare settings, thereby driving the growth of this segment over the forecast period.
The hospitals segment is expected to witness significant growth over the forecast period owing to rising cases of trauma.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key players, high per capita income, and favorable reimbursement policies. The region is expected to maintain its dominance over the forecast period due to factors such as increasing prevalence of chronic pain conditions and rising demand for non-narcotic alternatives for opioid therapy. In addition, growing awareness about chronic pain management among patients is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing with rapid economic development coupled with improving healthcare infrastructure in emerging countries such as China and India. Furthermore, government initiatives aimed at controlling drug abuse are also contributing towards regional growth.
Growth Factors:
- Increasing incidence of chronic pain: The global prevalence of chronic pain is estimated to be around 20%, and it is projected to increase to 30% by 2030. This will create a large pool of patients who will require treatment for their chronic pain, thereby driving the demand for pain management products.
- Growing awareness about the benefits of pain management products: There is a growing awareness among people about the benefits of using pain management products, which is helping to drive the market growth.
- Rising number of surgeries and other medical procedures: The number of surgeries and other medical procedures being performed is increasing every year, which is leading to an increase in the demand for post-operative analgesics and other related products.
- Technological advancements in Pain Management Product industry: There has been a significant advancement in technology in the Pain Management Product industry in recent years, with new product launches that are more effective and safer than older ones. This is helping to drive market growth. 5) Emerging markets offer untapped potential: The global Pain Management Product market offers significant potential for growth especially in emerging markets such as China, India, Brazil etc., where there exists a large population suffering from various types of chronic pains
Scope Of The Report
Report Attributes
Report Details
Report Title
Pain Management Product Market Research Report
By Type
Opioids, Non-narcotic Analgesics
By Application
Hospitals, Clinics, Homecare
By Companies
Pfizer, GSK, Novartis, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Merck, Depomed, Yunnan Baiyao, Teva, Johnson & Johnson, Allergan, Purdue Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Pain Management Product Market Report Segments:
The global Pain Management Product market is segmented on the basis of:
Types
Opioids, Non-narcotic Analgesics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Homecare
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- GSK
- Novartis
- Grunenthal
- Bayer
- Sanofi
- Eli Lilly
- AstraZeneca
- Merck
- Depomed
- Yunnan Baiyao
- Teva
- Johnson & Johnson
- Allergan
- Purdue Pharma
Highlights of The Pain Management Product Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Opioids
- Non-narcotic Analgesics
- By Application:
- Hospitals
- Clinics
- Homecare
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pain Management Product Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A pain management product is a medication, device, or therapy that is used to reduce the intensity or duration of pain.
Some of the major players in the pain management product market are Pfizer, GSK, Novartis, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Merck, Depomed, Yunnan Baiyao, Teva, Johnson & Johnson, Allergan, Purdue Pharma.
The pain management product market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pain Management Product Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pain Management Product Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pain Management Product Market - Supply Chain
4.5. Global Pain Management Product Market Forecast
4.5.1. Pain Management Product Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pain Management Product Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pain Management Product Market Absolute $ Opportunity
5. Global Pain Management Product Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pain Management Product Market Size and Volume Forecast by Type
5.3.1. Opioids
5.3.2. Non-narcotic Analgesics
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pain Management Product Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pain Management Product Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Homecare
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pain Management Product Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pain Management Product Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pain Management Product Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pain Management Product Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pain Management Product Demand Share Forecast, 2019-2026
9. North America Pain Management Product Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pain Management Product Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pain Management Product Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Homecare
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pain Management Product Market Size and Volume Forecast by Type
9.7.1. Opioids
9.7.2. Non-narcotic Analgesics
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pain Management Product Demand Share Forecast, 2019-2026
10. Latin America Pain Management Product Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pain Management Product Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pain Management Product Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Homecare
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pain Management Product Market Size and Volume Forecast by Type
10.7.1. Opioids
10.7.2. Non-narcotic Analgesics
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pain Management Product Demand Share Forecast, 2019-2026
11. Europe Pain Management Product Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pain Management Product Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pain Management Product Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Homecare
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pain Management Product Market Size and Volume Forecast by Type
11.7.1. Opioids
11.7.2. Non-narcotic Analgesics
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y rowth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pain Management Product Demand Share, 2019-2026
12. Asia Pacific Pain Management Product Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pain Management Product Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pain Management Product Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Homecare
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pain Management Product Market Size and Volume Forecast by Type
12.7.1. Opioids
12.7.2. Non-narcotic Analgesics
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pain Management Product Demand Share, 2019-2026
13. Middle East & Africa Pain Management Product Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pain Management Product Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pain Management Product Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Homecare
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pain Management Product Market Size and Volume Forecast by Type
13.7.1. Opioids
13.7.2. Non-narcotic Analgesics
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pain Management Product Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pain Management Product Market: Market Share Analysis
14.2. Pain Management Product Distributors and Customers
14.3. Pain Management Product Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. GSK
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Novartis
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Grunenthal
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bayer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sanofi
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Eli Lilly
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. AstraZeneca
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Merck
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Depomed
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Yunnan Baiyao
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Teva
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Johnson & Johnson
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Allergan
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Purdue Pharma
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
